TRLS — Trellus Health Cashflow Statement
0.000.00%
Last trade - 00:00- £3.23m
- -£9.47m
- $0.02m
- 30
- 26
- 17
- 13
Annual cashflow statement for Trellus Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.762 | -5.9 | -8.81 |
| Depreciation | |||
| Non-Cash Items | — | 0.139 | 0.185 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.111 | 0.959 | -0.531 |
| Change in Accounts Receivable | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -0.65 | -4.77 | -8.62 |
| Capital Expenditures | -0.674 | -3.72 | -2.91 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Cash from Investing Activities | -0.674 | -3.72 | -2.91 |
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | 5.01 | 38.5 | 0 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 3.68 | 28.3 | -12.9 |